Winterlight has developed a tablet-based assessment that utilizes speech analysis to detect cognitive impairment associated with dementia and mental illness. This technology provides a fast, objective, and remote method for monitoring cognitive health in clinical trials, senior care, and life science research.
Funding
$4.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
HVFounders
Product
Problem
Traditional neurological assessments for cognitive impairment are often slow, subjective, difficult to administer remotely, and require specialized personnel. Detecting cognitive decline associated with conditions like dementia and mental illness can be challenging, especially in the early stages.
Solution
Winterlight Labs offers a tablet-based assessment that analyzes speech patterns to objectively detect and monitor cognitive impairment. The technology extracts speech-based digital biomarkers from short speech samples, providing a fast, objective, and remote method for assessing cognitive health. This assessment is utilized in clinical trials, senior care settings, and life science research to track changes in cognitive function and identify treatment responses. The platform automates the review of clinical assessment administration and scoring, providing reliable auditing and analysis.
Target Audience
The primary target audience includes life science companies conducting clinical trials, senior care facilities monitoring cognitive health, and researchers studying neurological and psychiatric diseases.
Features
- Tablet-based assessment for convenient and standardized data collection.
- Speech analysis algorithms that extract clinically validated digital biomarkers.
- Remote administration capabilities for decentralized patient assessments.
- Automated quality assurance for clinical assessment administration and scoring.
- API access for integration with existing applications and devices.
- Support for site onboarding, data collection, speech analysis, and results interpretation in clinical trials.